Released Apr 15, 2025, after the close
10-K filed Apr 15, 2025, 105 days after period end · 0001437749-25-012050
Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$2.01M$2.01M derived−10.9% vs Q4 2023−19.9% vs Q3 2024
Net Income-$2.04M-$2.04M derivedN/M vs Q4 2023N/M vs Q3 2024
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$1,511,061+0.1%
Operating Incomederived-$2,042,287N/M
Operating Cash Flowderived-$1,511,488N/M
Free Cash Flowderived-$1,515,016—
Margins · derived
Gross margin75.0%+8.3 pt vs Q4 2023
Operating margin-101.4%−13.9 pt vs Q4 2023
Net margin-101.1%−15.3 pt vs Q4 2023
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Revenue | $2.01M | $2.26M | $2.24M | $2.85M |
| Net Income | -$2.04M | -$1.94M | -$1.97M | -$1.12M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Milestone Scientific Inc. · CIK 855683 · Engraved from SEC EDGAR